Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Bispecific Antibodies: Clinical Trial Tracker - Product Thumbnail Image

Bispecific Antibodies: Clinical Trial Tracker

  • Clinical Trials
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Product Thumbnail Image

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020

  • Report
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030

  • Report
  • 347 Pages
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • 270 Pages
From
Bispecific Antibody Therapeutics Market (2nd Edition), 2014 - 2024 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (2nd Edition), 2014 - 2024

  • Report
  • 247 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Report
  • 1275 Pages
From
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2018 - Product Thumbnail Image

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2018

  • Report
  • 141 Pages
From
Angiopoietin 1 Receptor - Pipeline Review, H1 2018 - Product Thumbnail Image

Angiopoietin 1 Receptor - Pipeline Review, H1 2018

  • Report
  • 106 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H2 2017

  • Report
  • 1120 Pages
From
Angiopoietin 1 Receptor - Pipeline Review, H2 2017 - Product Thumbnail Image

Angiopoietin 1 Receptor - Pipeline Review, H2 2017

  • Report
  • 94 Pages
From
Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p140 TEK or CD20 - Product Thumbnail Image

Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p140 TEK or CD20

  • Report
  • 86 Pages
From
Liver Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H2 2016

  • Report
  • 1171 Pages
From
Liver Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H1 2016

  • Report
  • 1073 Pages
From
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016

  • Report
  • 131 Pages
From
Tie-2 modulators -Pipeline Insight, 2018 - Product Thumbnail Image

Tie-2 modulators -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Tie-2 Receptor Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

Tie-2 Receptor Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016

  • Report
  • 124 Pages
From
Loading Indicator
adroll